Cargando…
Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer
The glycoprotein CD44 is a key regulator of malignant behaviors in breast cancer cells. To date, hyaluronic acid (HA)-CD44 signaling pathway has been widely documented in the context of metastatic bone diseases. Core 1 β1,3-galactosyltransferase (C1GALT1) is a critical enzyme responsible for the elo...
Autores principales: | Lin, Neng-Yu, Lee, Jian-Jr, Chen, Syue-Ting, Lin, Jung-An, Lin, Chia-Hsuan, Lin, Hsuan-Yu, Su, Yong-Han, Chen, Cheng-Chang, Lin, Mei-Chun, Kuo, Ching-Ying, Huang, Min-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320474/ https://www.ncbi.nlm.nih.gov/pubmed/37040171 http://dx.doi.org/10.1158/1541-7786.MCR-22-0907 |
Ejemplares similares
-
Role of Truncated O-GalNAc Glycans in Cancer Progression and Metastasis in Endocrine Cancers
por: Pinto, Diluka, et al.
Publicado: (2023) -
Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics
por: Wang, Shuaishuai, et al.
Publicado: (2021) -
Overexpression of GalNAc-transferase GalNAc-T3 Promotes Pancreatic Cancer Cell Growth
por: Taniuchi, Keisuke, et al.
Publicado: (2011) -
Expression of alpha-GalNAc glycoproteins by breast cancers.
por: Brooks, S. A., et al.
Publicado: (1995) -
The GalNAc-T Activation (GALA) Pathway: Drivers and markers
por: Chia, Joanne, et al.
Publicado: (2019)